2025-12-30 - Analysis Report
Here's an analysis of Procter & Gamble (PG) based on the data you provided:

**0) Data Summary:**

*   **Ticker:** PG
*   **Company Name:** Procter & Gamble Co
*   **Current Price:** 144.74
*   **Comparison:** S&P 500 (VOO)

**1) Return Rate Comparison & Analysis:**

*   **Company Overview:** Procter & Gamble is a multinational consumer goods corporation focused on providing branded consumer packaged goods to consumers across the world.
*   **PG Cumulative Return:** 26.38%
*   **VOO Cumulative Return:** 103.21%
*   **Divergence:** -74.8
*   **Relative Divergence:** 5.3 (Meaning the divergence is near the bottom of its historical range.)
*   **Analysis:** PG has significantly underperformed the S&P 500 over the analyzed period. The large negative divergence (-74.8) highlights this underperformance. The relative divergence of 5.3 suggests this underperformance is near the worst it has been historically within the given timeframe.

**Alpha/Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 21.0% | 7.9%  | -8.0% | 0.0  | 214.8  |
| 2016-2018  | 9.0%  | 67.3% | -6.0% | 0.1  | 214.9  |
| 2017-2019  | 24.0% | 70.4% | 2.0%  | 0.3  | 292.0  |
| 2018-2020  | 27.0% | 78.8% | 4.0%  | 0.4  | 325.3  |
| 2019-2021  | 41.0% | 78.8% | -5.0% | 0.5  | 382.4  |
| 2020-2022  | 13.0% | 79.4% | 13.0% | 0.6  | 354.3  |
| 2021-2023  | 26.0% | 79.4% | 24.0% | 0.4  | 342.6  |
| 2022-2024  | 9.0%  | 79.4% | -12.0% | 0.4  | 391.9  |
| 2023-2025  | -18.0% | 80.1% | -85.0% | 0.1  | 338.4  |

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly year to year, showing periods of strong growth followed by negative returns recently.
*   **MDD (Maximum Drawdown):** High drawdowns in recent periods suggest significant volatility.
*   **Alpha:** Alpha is frequently negative, indicating underperformance relative to its benchmark risk-adjusted return. The most recent period (2023-2025) shows a dramatic negative alpha.
*   **Beta:** Beta remains relatively low, suggesting PG is less volatile than the overall market.
*   **Cap(B):**  Market capitalization fluctuates reflecting changing investor sentiment and market conditions.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 144.74
*   **Last-Market Price:** 144.57, Change: -0.12 (Slight decrease)
*   **5-day SMA:** 143.91
*   **20-day SMA:** 143.93
*   **60-day SMA:** 147.43
*   **Analysis:** The current price is slightly below the 60-day moving average, but around 5-day, and 20-day SMA, indicating a potential recent downward trend after being higher.

**3) Indicators Analysis:**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment Recommended) - Suggests the stock is reasonably safe.
*   **RSI (Relative Strength Index):** 52.97 (Neutral) - Doesn't indicate overbought or oversold conditions.
*   **PPO (Percentage Price Oscillator):** 0.21 (Positive) - Suggests a slight upward trend.
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90)" indicates a strong buy signal based on the indicator's criteria. The recommendation is to invest a small amount monthly.
*   **Recent Divergence Change:** +1.0 (Short-term increase) - Suggests a recent short-term price increase relative to the comparison.
*   **Fluctuation:** The negative change (-0.12) from the previous close is small.
*   **Expected Return:** -0.5% - Negative expected return relative to S&P 500 over the long term.

**4) Recent News & Significant Events:**

*   Several news articles focus on PG's performance, including:
    *   Analyses of its historical performance.
    *   CEO changes and earnings dates.
    *   Stake cut by Sunburst Financial Group LLC.
    *   Discussion of earnings and potential weaknesses in specific product areas like Baby Care and China.
*   **Analysis:** The news is mixed. Some articles analyze past performance, while others discuss potential challenges and investor concerns. The stake cut by Sunburst Financial Group is a potentially negative signal. Focus on upcoming earnings and CEO transition suggest a period of change and scrutiny.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.92)
*   **Opinions:** 22
*   **Target Price:** Avg: 168.95 / High: 186.00 / Low: 148.00
*   **Analysis:** Analysts generally have a positive outlook on PG with a "Buy" consensus and a target price significantly higher than the current price. *However, it is important to note that no recent changes were provided.*

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출         |
|------------|------|--------------|
| 2025-10-24 | 2    | 22.39 B$     |
| 2025-04-24 | 1.58 | 19.78 B$     |
| 2025-01-22 | 1.94 | 21.88 B$     |
| 2024-10-18 | 1.65 | 21.74 B$     |
| 2025-10-24 | 1.65 | 21.74 B$     |

*   **Analysis:** The earnings data shows a slight upward trend in EPS and Revenue over the past few quarters. The most recent quarter (2025-10-24) has the highest EPS and revenue figures.  There is a duplicate entry for 2025-10-24 (corrected in Financial Information).

**6) Financial Information:**

Revenue and Profitability:

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-09-30   | $22.39B     | 51.37%        |
| 2025-06-30   | $20.89B     | 49.11%        |
| 2025-03-31   | $19.78B     | 50.98%        |
| 2024-12-31   | $21.88B     | 52.39%        |
| 2024-09-30   | $21.74B     | 52.06%        |

Capital and Profitability:

| Quarter      | Equity      | ROE   |
|--------------|-------------|-------|
| 2025-09-30   | $53.27B     | 8.92% |
| 2025-06-30   | $52.01B     | 6.95% |
| 2025-03-31   | $52.27B     | 7.21% |
| 2024-12-31   | $51.17B     | 9.05% |
| 2024-09-30   | $51.84B     | 7.64% |

*   **Analysis:** Revenue shows quarter-to-quarter fluctuation, with peak values in the 2025-09-30 quarter. Profit margin is relatively consistent, fluctuating around 50-52%. Equity has been steadily increasing, indicating a strengthening financial position. ROE (Return on Equity) has fluctuated, reflecting variations in profitability relative to equity.

**7) Comprehensive Analysis (Summary):**

Procter & Gamble has underperformed the S&P 500 significantly. While analyst consensus is positive and recent earnings show some strength, negative news headlines and a stake cut suggest underlying concerns. The MRI indicates a relatively safe investment, but the negative expected return compared to the S&P 500 is concerning.  The technical indicators provide a mixed picture. Overall, while PG shows signs of stability and potential for growth based on analyst targets and earnings, the significant underperformance relative to the market and negative expected return should be considered carefully. Recent news headlines also show underlying concerns about certain aspects of the business. The analysis suggest a cautious approach to investing in PG at this time.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.